Thus, elevation of these processes could be reflective of the increase in mTOR signaling previously observed in FXS patients and Fmr1-KO mice, and upregulation of ribosome biogenesis could in turn contribute to increased translation in Fmr1-KO mice [53,54]. The gene discussed is MTOR; the disease is fragile X syndrome.